BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37620975)

  • 1. Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis.
    Dong S; Miao X; Zhang K; Zhu X; Gao Y; Chen H
    World J Surg Oncol; 2023 Aug; 21(1):262. PubMed ID: 37620975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation.
    Zhang L; Zhang X; Wu B; Han X; Guo C; Li B; Jing H; Cheng W
    Pathol Oncol Res; 2023; 29():1611175. PubMed ID: 37325466
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
    Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
    Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference values of the carotid elastic modulus using shear wave elastography and arterial stiffness change in coronary slow flow.
    Wang YH; Kang YQ; Jin XY; Meng PP; Guan ZY; Jia DL; Gao MY; Ma CY
    Eur J Radiol; 2022 Dec; 157():110582. PubMed ID: 36335882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    Uesato Y; Sasahira N; Ozaka M; Sasaki T; Takatsuki M; Zembutsu H
    PLoS One; 2020; 15(7):e0235623. PubMed ID: 32614932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden.
    Liu L; Xu HX; Wang WQ; Wu CT; Xiang JF; Liu C; Long J; Xu J; Fu de L; Ni QX; Houchen CW; Postier RG; Li M; Yu XJ
    Oncotarget; 2016 Feb; 7(5):5943-56. PubMed ID: 26745601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
    Lambert A; Jarlier M; Gourgou Bourgade S; Conroy T
    PLoS One; 2017; 12(9):e0183288. PubMed ID: 28931010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CA724 has no diagnostic value for gastrointestinal tumors.
    Cao H; Zhu L; Li L; Wang W; Niu X
    Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate-adjusted analysis at the pre-adjuvant chemotherapy timing.
    Fu N; Qin K; Li J; Jin J; Jiang Y; Deng X; Shen B
    Cancer Med; 2022 Sep; 11(18):3397-3406. PubMed ID: 35434972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores.
    Hwang I; Kang J; Ip HNN; Jeong JH; Kim KP; Chang HM; Yoo C; Ryoo BY
    Invest New Drugs; 2019 Jun; 37(3):584-590. PubMed ID: 30324344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system.
    Yang C; Cheng H; Luo G; Lu Y; Guo M; Jin K; Wang Z; Yu X; Liu C
    Eur J Surg Oncol; 2017 Nov; 43(11):2112-2118. PubMed ID: 28802662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis.
    Tian BW; Han CL; Wang HC; Yan LJ; Ding ZN; Liu H; Mao XC; Tian JC; Xue JS; Yang LS; Tan SY; Dong ZR; Yan YC; Wang DX; Li T
    Clin Exp Metastasis; 2023 Aug; 40(4):255-287. PubMed ID: 37308706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential high-intensity focused ultrasound treatment combined with chemotherapy for inoperable pancreatic cancer: a retrospective analysis for prognostic factors and survival outcomes.
    Dong S; Zhong A; Zhu H; Wang K; Cheng CS; Meng Z
    Int J Hyperthermia; 2023; 40(1):2278417. PubMed ID: 37945310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
    Huang L; Fang J; Wu J; Zhou X; Wei H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Imaging Using Single Track Location Shear Wave Elastography: Monitoring the Progression of Murine Pancreatic Tumor Liver Metastasis In Vivo.
    Ahmed R; Ye J; Gerber SA; Linehan DC; Doyley MM
    IEEE Trans Med Imaging; 2020 Jul; 39(7):2426-2439. PubMed ID: 32012006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study.
    Deng Y; Chen Q; Chen J; Zhang Y; Zhao J; Bi X; Li Z; Zhang Y; Huang Z; Cai J; Zhao H
    BMC Surg; 2023 May; 23(1):131. PubMed ID: 37194000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer.
    Qiu X; Shi Z; Tong F; Lu C; Zhu Y; Wang Q; Gu Q; Qian X; Meng F; Liu B; Du J
    Hum Vaccin Immunother; 2023 Dec; 19(1):2178791. PubMed ID: 36809234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.